03/25/2020 - Update on InnomarPharmacy and InnomarClinic hours and availability

InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.

Learn more.

Insights

Innomar Strategies

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Sandra Anderson

Commercialization and Strategy

March 2020

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Sandra Anderson

Commercialization and Strategy

February 2020

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Sandra Anderson

Commercialization and Strategy

January 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Innomar Strategies

December 2019

Manufacturers

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

Innomar Strategies

January 2019

InnomarLive Summary: Healthcare Innovation

Innomar Strategies

December 2018

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Innomar Strategies

May 2018

Insights

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

InnomarLive 2019: Commercializing in Canada

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

InnomarLive Summary: Healthcare Innovation

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Infographic: The Route to Market Access in Canada

Infographic: The Road to Commercialization in Canada

Insight Series: Biosimilars in Canada

Drug Reimbursement in Canada

Improved Health Outcomes in Patients Receiving Health Case Management

Understanding the Journey of a Person with a Rare Disease

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Case Study: Patient-centric Care in Rare Disease

Future of Patient Support Programs in Canada

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Case Study: Discovering New Opportunities for Growth in a Niche Market

Support Programs Designed to Assist Patients and Their Families

Big Wins in Record Time for Gaining Market Access with Phase II Data

Nurse-led Health Case Management

Explore More by Topic

Affordability

Analytics

Biosimilars

Commercialization

Data

Legislation